Developing second generation antibody-drug conjugates: the quest for new technologies.

J Med Chem

Lead Generation to Compound Realization, Sanofi-Aventis , 94400 Vitry sur Seine, France.

Published: October 2014

The field of antibody-drug conjugates (ADCs) has gained significant momentum after the recent regulatory approval of two ADCs, and significant research efforts are directed to identify more effective payloads and simplify current manufacturing challenges.

Download full-text PDF

Source
http://dx.doi.org/10.1021/jm501298kDOI Listing

Publication Analysis

Top Keywords

antibody-drug conjugates
8
developing second
4
second generation
4
generation antibody-drug
4
conjugates quest
4
quest technologies
4
technologies field
4
field antibody-drug
4
conjugates adcs
4
adcs gained
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!